To include your compound in the COVID-19 Resource Center, submit it here.

Chinese biotech KBP raises $76 million series A

KBP Biosciences Co. Ltd. (Jinan, China) raised a $76 million series A

Read the full 120 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE